Thank you for your message about A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients. You must verify your email address to receive further communication about this trial. Please check your email for a verification message.
We're sorry, your verification code has expired. Please submit another form using the button below to receive communications about your preferred clinical trial study.